Skip to main content

Advertisement

Figure 2 | BMC Cancer

Figure 2

From: Comparative benefit from small tumour size and adjuvant chemotherapy: clues for explaining breast cancer mortality decline

Figure 2

Adjuvant-CMF-related and tumour-size-related absolute recurrence risk reduction (ARR) for 386 early breast cancer patients undergoing mastectomy only or mastectomy plus adjuvant CMF. Adjuvant-CMF-related ARR = Recurrence risk for controls - Recurrence risk for CMF treated patients. Tumour-size-related ARR = Recurrence risk for T1 – recurrence risk for T2/T3.

Back to article page